Genetic instability and the etiology of somatic PIG-A mutations in paroxysmal nocturnal hemoglobinuria

Blood Cells, Molecules, and Diseases

Volumn 25, Issue 2, 1999, Pages 81-91

  Purow, David B ^a   Howard, Thad A ^a   Marcus, Stacy J ^a   Rosse, Wendell F ^a   Ware, Russell E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; GENE LOCUS; GENE MUTATION; GENETIC RECOMBINATION; HUMAN; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0033031417     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1999.0229     Document Type: Article

References (58)

1. Rosse W F. Paroxysmal nocturnal hemoglobinuria as a molecular disease. Medicine. 76:1997;63.
2. Ware R E, Hall S G, Rosse W F. Paroxysmal nocturnal hemoglobinuria with onset in childhood and adolescence. N Engl J Med. 325:1991;991.
3. Medof M E, Walter E I, Roberts W L, Haas R, Rosenberry T L. Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid. Biochemistry. 25:1986;6740.
4. Selvaraj P, Rosse W F, Silber R, Springer T A. The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria. Nature. 333:1988;565.
5. Takahaski M, Takeda J, Hirose S, Hyman R, Inoue N, Miyata T, Ueda E, Kitani T, Medof M E, Kinoshita T. Deficient biosynthesis of N-Acetylglucosaminyl-phosphatidyl-inositol, the first intermediate of glycosyl phosphatidyl-inositol anchor biosynthesis, in cell lines established from patients with paroxysmal nocturnal hemoglobinuria. J Exp Med. 177:1990;517.
6. Mahoney J F, Urakaze M, Hall S, DeGasperi R, Chang H-M, Sugiyama E, Warren C D, Borowitz M, Nicholson-Weller A, Rosse W F, Yeh E TH. Defective glycosylphosphatidyl-inositol anchor synthesis in paroxysmal nocturnal hemoglobinuria granulocytes. Blood. 79:1992;1400.
7. Rosse W F. The glycolipid anchor of membrane surface proteins. Sem Hematol. 30:1993;219.
8. Rosse W F. Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria. Blood. 75:1990;1595.
9. Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T, Takahashi M, Kitani T, Kinoshita T. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 73:1993;703.
10. Bessler M, Mason P J, Hillmen P, Miyata T, Yamada N, Takeda J, Luzzatto L, Kinoshita T. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J. 13:1994;110.
11. Ware R E, Rosse W F, Howard T A. Mutations within the Pig-a gene in pateints with paroxysmal nocturnal hemoglobinuria. Blood. 83:1994;2418.
12. Yamada N, Miyata T, Maeda K, Kitani T, Takeda J, Kinoshita T. Somatic mutations of the PIG-A gene found in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood. 85:1995;885.
13. Ostendorf T, Nischan C, Schubert J, Grussenmeyer T, Scholz C, Zielinska-Skowronek M, Schmidt R E. Heterogeneous PIG-A mutations in different cell lineages in paroxysmal nocturnal hemoglobinuria. Blood. 85:1995;1640.
14. Pramoonjago P, Wanachiwanawin W, Chinprasertsak S, Pattanapanyasat K, Takeda J, Kinoshita T. Somatic mutations of PIG-A in Thai patients with paroxysmal nocturnal hemoglobinuria. Blood. 86:1995;1736.
15. Rosse W F, Ware R E. The molecular basis of paroxysmal nocturnal hemoglobinuria (review). Blood. 86:1995;3277.
16. Bessler M, Mason P, Hillmen P, Luzzatto L. Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria. Lancet. 343:1994;951.
17. Endo M, Ware R E, Vreeke T M, Singh S P, Howard T A, Tomita A, Holguin M H, Parker C J. Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria. Blood. 87:1996;2546.
18. Nishimura J, Inoue N, Wada H, Ueda E, Pramoonjago P, Hirota T, Machii T, Kageyama T, Kanamaru A, Takeda J, Kinoshita T, Kitani T. A patient with paroxysmal nocturnal hemoglobinuria bearing four independent PIG-A mutant clones. Blood. 89:1997;3470.
19. Albertini R J, Castle K L, Borcherding W R. T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood. Proc Natl Acad Sci USA. 79:1982;6617.
20. O'Neill J P, McGinniss M J, Berman J K, Sullivan L M, Nicklas J A, Albertini R J. Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans. Mutagenesis. 2:1987;87.
21. Stern M H, Lipkowitz S, Aurias A, Griscelli C, Thomas G, Kirsch I R. Inversion of chromosome 7 in ataxia-telangiectasia is generated by a rearrangement between T-cell receptor b and T cell receptor g genes. Blood. 74:1989;2076.
22. Lipkowitz S, Stern M-H, Kirsch I R. Hybrid T cell receptor genes formed by interlocus recombination in normal and ataxia-telangiectasia lymphocytes. J Exp Med. 172:1990;409.
23. Denning S M, Tuck D T, Singer K H, Haynes B F. Human thymic epithelial cells function as accessory cells for autologous mature thymocyte activation. J Immunol. 138:1987;680.
24. Norris J, Hall S, Ware R E, Kamitani T, Chang H-M, Yeh E TH, Rosse W F. Glycosyl-phosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria: Partial or complete defect in an early step. Blood. 83:1994;816.
25. Hillmen P, Bessler M, Mason P J, Watkins W M, Luzzatto L. Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci USA. 90:1993;5272.
26. Lipkowitz S, Garry V F, Kirsch I R. Interlocus V-J recombination measures genomic instability in agriculture workers at risk for lymphoid malignancies. Proc Natl Acad Sci USA. 89:1992;5301.
27. Nicklas J A, Hunter T C, Sullivan L M, Berman J K, O'Neill J P, Albertini R J. Molecular analyses of in vivo hprt mutations in human T-lymphocytes. I. Studies of low frequency 'spontaneous' mutants by Southern blots. Mutagenesis. 2:1987;341.
28. Fuscoe J C, Zimmerman L J, Harrington-Brock K, Moore M M. Deletion mutations in the hprt gene of T-lymphocytes as a biomarker for genomic rearrangements important in human cancers. Carcinogenesis. 15:1994;1463.
29. Ionov Y, Peinado M A, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature. 363:1993;558.
30. Thibodeau S N, Bren G, Schaid B. Microsatellite instability in cancer of the proximal colon. Science. 260:1993;816.
31. Wada C, Shionoya S, Fujino Y, Tokuhiro H, Akahoshi T, Uchida T, Ohtani H. Genomic instability of microsatellite repeats and its association with the evolution of chronic myelogenous leukemia. Blood. 83:1994;3449.
32. Robledo M, Martinez B, Arranz E, Trujillo M J, Ageitos A G, Rivas C, Benitez J. Genetic instability of microsatellites in hematological neoplasms. Leukemia. 9:1995;960.
33. Gartenhaus R, Johns M M, Wang P, Rai K, Sidransky D. Mutator phenotype in a subset of chronic lymphocytic leukemia. Blood. 87:1996;38.
34. Gonzalez-Zulueta M, Ruppert J M, Tokino K, Tsai Y C, Spruck C H 3d, Miyao N, Nichols P W, Hermann G G, Horn T, Steven K. Microsatellite instability in bladder cancers. Cancer Res. 53:1993;5620.
35. Han H-J, Yanagisawa A, Kato Y, Park J-G, Makamura Y. Genetic instability in pancreatic cancer and poorly differentiated gastric cancer. Cancer Res. 53:1993;5087.
36. Merlo A, Mabry M, Gabrielson E, Vollmer R, Baylin S B, Sidransky D. Frequent microsatellite instability in primary small cell lung cancer. Cancer Res. 54:1994;2098.
37. + tumor cells. Cell. 75:1993;1227.
38. Fishel R, Lescoe M K, Rao M R, Copeland N G, Jenkins N A, Garber J, Kane M, Kolodner R. The human mutator gene homologue MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 75:1993;1027.
39. Bronner C E, Baker S M, Morrison P T, Warren G, Smith L G, Lescoe M K, Kane M, Earabino C, Lipford J, Lindblom A, Tannergard P, Bollag R J, Godwin A R, Ward D C, Nordensjold M, Fishel R, Kolodner R, Liskay M. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature. 368:1994;258.
40. Loeb L A. Microsatellite instability: marker of a mutator phenotype in cancer. Canc Res. 54:1994;5059.
41. Coleman W B, Tsongalis G J. Multiple mechanisms account for genomic instability and molecular mutation in neoplastic transformation. Clin Chem. 41:1995;644.
42. Lehmann Ar, Carr A M. The ataxia-telangiectasia gene: A link between checkpoint controls, neurodegeneration and cancer. Trends in Genetics. 11:1995;375.
43. Cahill D P, Lengauer C, Yu J, Riggins G J, Willson J KV, Markowitz S D, Kinzler K W, Vogelstein B. Mutations of mitotic checkpoint genes in human cancers. Nature. 392:1998;300.
44. Parsons R, Li G-M, Longley M, Modrich P, Liu B, Berk T, Hamilton S R, Kinzler K W, Vogelstein B. Mismatch repair deficiency in phenotypically normal human cells. Science. 268:1995;738.
45. Radman M, Matic I, Halliday J A, Taddei F. Editing DNA replication and recombination by mismatch repair: from bacterial genetics to mechanisms of predisposition to cancer in humans. Phil Trans R Soc Lond. 347:1995;97.
46. Bhattacharyya N P, Skandalis A, Ganesh A, Groden J, Meuth M. Mutator phenotypes in human colorectal carcinoma cell lines. Proc Natl Acad Sci USA. 91:1994;6319.
47. Albertini R J. Somatic gene mutations in vivo as indicated by the 6-thioguanine-resistant T-lymphocytes in human blood. Mut Res. 150:1985;411.
48. Tates A D, van Dam F J, van Mossel H, Schoemaker H, Thijssen J CP, Woldring V M, Zwinderman A H, Natarajan A T. Use of the clonal assay for the measurement of frequencies of HPRT mutants in T-lymphocytes from five control populations. Mut Res. 253:1991;199.
49. Robinson D R, Goodall K, Albertini R J, O'Neill J P, Finette B, Sala-Trepat M, Moustacchi E, Tates A D, Beare D M, Green M HL, Cole J. An analysis of in vivo hprt mutant frequency in circulating T-lymphocytes in the normal human population: A comparison of four datasets. Mut Res. 313:1994;227.
50. + T cells. J Exp Med. 171:1990;1981.
51. Langlois R G, Bigbee W L, Hensen R H. Flow cytometric characterization of normal and variant cells with monoclonal antibodies specific for glycophorin A. J Immunol. 134:1985;4009.
52. Langlois R B, Bigbee W L, Hensen R H. Measurements of the frequency of human erythrocytes with gene expression loss phenotypes at the glycophorin A locus. Hum Genet. 74:1986;353.
53. Huttner E, Mergner U, Braun R, Schoneich J. Increased frequency of 6-thioguanine-resistant lymphocytes in peripheral blood of workers employed in cyclophosphamide production. Mut Res. 243:1990;101.
54. Homans A C, Poseno T, Dickerman J D, Forman E N, Finette B A. Monitoring for chemotherapy genotoxicity in pediatric oncology patients utilizing HPRT. Blood. 86:1995;436a.
55. Chen C-L, Fuscoe J C, Liu Q, Relling M V. Etoposide causes illegitimate V(D)J recombination in human lymphoid leukemic cells. Blood. 88:1996;2210.
56. Hattori H, Machii T, Ueda E, Shibano M, Kageyama T. Increased frequency of somatic muations at glycophorin A loci in patients with aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria. Br J Haematol. 98:1997;384.
57. Luzzatto L, Bessler M, Rotoli B. Somatic mutations in paroxysmal nocturnal hemoglobinuria: A blessing in disguise. Cell. 88:1997;1.
58. Richards B, Zhang H, Phear G, Meuth M. Conditional mutator phenotypes in hMSH2-deficient tumor cell lines. Science. 277:1997;1523.